• Imported new Tylenol to be listed for reimb from Jan
• by Lee, Tak-Sun Dec 26, 2022 06:07am

• Policy
• Dong-A ST’s Forxiga prodrug Dapapro 5mg listed for reimb
• by Lee, Tak-Sun Dec 26, 2022 06:07am

• Policy
• Zavicefta has been approved for domestic use
• by Lee, Hye-Kyung Dec 26, 2022 06:06am

• Policy
• Exclude Australia from the drug price reference country?
• by Lee, Tak-Sun Dec 26, 2022 06:06am

• Company
• Nubeqa, approval for a combination therapy indication
• by Eo, Yun-Ho Dec 23, 2022 06:06am

• Company
• 1 of 2 patent suits filed this year proceed to the 2nd round
• by Kim, Jin-Gu Dec 23, 2022 06:06am

• Policy
• Revlimid's benefit for multiple myeloma maintenance therapy
• by Lee, Tak-Sun Dec 23, 2022 06:05am

• Policy
• Lucentis biosimilar price set 63% lower than original
• by Lee, Tak-Sun Dec 23, 2022 06:05am

• InterView
• IL-23 Continued research on inflammatory pathways
• by Dec 23, 2022 06:05am

• InterView
• From domestic sales to the global brand general
• by Dec 22, 2022 05:53am